{"schema_version":"secwatch.filing_event.v1","accession":"0001023024-24-000059","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.925136+00:00","generated_at":"2026-06-02T00:07:06.283582+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"ANI Pharmaceuticals CEO presents at investor conference; no financial results disclosed in filing","bullets":["President & CEO Nikhil Lalwani participated in Capital One Securities Biotech/Biopharma Disruptors Event on May 14, 2024.","Investor presentation attached as Exhibit 99.1 was referenced but not included in the provided text.","No new financial or operational data, guidance changes, or material events can be extracted from the filing alone."],"urls":{"canonical":"https://secwatch.observer/filing/0001023024-24-000059","json":"https://secwatch.observer/filing/0001023024-24-000059.json","markdown":"https://secwatch.observer/filing/0001023024-24-000059.md","text":"https://secwatch.observer/filing/0001023024-24-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000102302424000059/0001023024-24-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000102302424000059/ani-20240514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T00:07:06.283582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}